Article

Tthestreet.com on 2023-10-11 12:14

Novo Nordisk, Eli Lilly leap as Ozempic show promise in kidney patient treatment

Ozempic, the diabetes treatment often prescribed for weight loss, is also proving highly-effective in treating patients with chronic kidney disease.

Denmark

Martin Baccardax

Related news

Can biotech startups upstage Eli Lilly and Novo Nordisk?The Economist
Denmark
Here’s Why Ozempic And Mounjaro Rivals Won’t Topple Weight Loss Drugmakers Novo Nordisk And Eli Lilly Anytime Soon Forbes
MNovo Nordisk, Eli Lilly are tackling provide points mvtelegraph.com
France , Denmark , Indiana , Germany , Triangle Park
FEli Lilly & Co: Eli Lilly races to boost capacity for rival to Novo Nordisk weight-loss drug ft.com
Inside Novo Nordisk, the Company Behind Ozempic and Wegovy The New York Times
Denmark
MNovo Nordisk sues pharmacies over impure Wegovy, Ozempic dupes mvtelegraph.com
Denmark , Florida , Norway , Oslo Fylke
Novo Nordisk Will Lower Insulin Prices Up To 75%, Following Eli Lilly Forbes
France
MEli Lilly guarantees insulin costs will not go up; Novo Nordisk, Sanofi hedge mvtelegraph.com
United States , Denmark , Vermont , Illinois
Weight-Loss Drug Frenzy Drives Eli Lilly And Novo Nordisk Stock To Record Highs Forbes
Denmark , Wall Street
UInsulin API Market Size Current and Future | Novo Nordisk, Sanofi-Aventis, Eli Lilly, Tonghua Dongbao, Ganlee unlvrebelyell.com
Africa , Middle East , Pacific Ocean , Asia
MPfizer enters weight reduction drug market with Novo Nordisk, Eli Lilly mvtelegraph.com
Wall Street
Novo Nordisk plans to cut insulin prices up to 75%, following Eli Lilly ocregister.com
Novo Nordisk and Eli Lilly hoover up smaller obesity drug groups Financial Times
GGlobal Thyroid Hormone Disorder Drug Market 2022-28 Growth by Leading Firms: Novo Nordisk,Sanofi,Merck,Eli Lilly,AstraZeneca,AbbVie galleonnews.com
LEndocrinology Drugs Market Size, Key Opportunities, Strategic Assessment, Strong Revenue | Oprating Vendors: AbbVie, Merck, AstraZeneca, Eli Lilly, Sanofi, Novo Nordisk…liverpoolstudentmedia.com
Africa , Middle East , Mexico , Brazil , Latin America
FZealand Pharma AS: Novo Nordisk and Eli Lilly set to face new challenger in weight-loss race ft.com
G“Global Insulin Pen Market Growth by 2028 Key Players:Novo Nordisk ,Eli Lilly ,Sanofi ,BD ,Ypsomed Holding ,Dongbao ,Owen Mumford ,Ganlee ,”galleonnews.com
Eli Lilly wins FDA nod for obesity drug that rivals Wegovy, Ozempic - Wed, 08 Nov 2023 PST syndication.washingtonpost.com
Europe , New York
Novo Nordisk Buys Hypertension Drug Ocedurenone For $1.3 Billion—Expanding Ozempic Maker’s Arsenal Forbes
France , Denmark
BRoche Strikes $3.1 Billion Deal for Obesity Drugmaker. It Hopes to Compete with Eli Lilly, Novo Nordisk. 2 min read barrons.com
Switzerland